Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 10 | 98459662 | missense variant | C/T | snv | 2.4E-05 | 2.1E-05 |
|
0.010 | 1.000 | 1 | 2003 | 2003 | ||||||||
|
1.000 | 0.120 | 10 | 98459725 | missense variant | T/A | snv |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 0 | |||||||||||
|
10 | 98480617 | intron variant | C/T | snv | 9.4E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 10 | 98482732 | missense variant | C/T | snv | 8.0E-06 |
|
0.010 | 1.000 | 1 | 2003 | 2003 | |||||||||
|
1.000 | 0.120 | 10 | 98482733 | stop gained | G/A | snv | 1.6E-05 | 1.4E-05 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 0 | |||||||||
|
1.000 | 0.120 | 10 | 98490051 | frameshift variant | TT/- | del | 1.8E-04 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 0 | ||||||||||
|
1.000 | 0.120 | 10 | 98490103 | stop gained | G/A;C | snv | 8.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 0 | ||||||||||
|
1.000 | 0.040 | 10 | 98529811 | intron variant | T/C | snv | 3.5E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98533943 | intron variant | T/C;G | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.120 | 10 | 98540425 | intron variant | C/T | snv | 0.40 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 10 | 98551693 | intron variant | T/C | snv | 5.3E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98551910 | intron variant | G/A | snv | 0.41 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98553285 | intron variant | G/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 10 | 98553806 | intron variant | C/T | snv | 0.40 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98554582 | intron variant | G/A | snv | 0.27 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98555795 | intron variant | C/T | snv | 9.8E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98558310 | intron variant | C/T | snv | 0.45 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98558679 | intron variant | A/G | snv | 0.85 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98558936 | intron variant | C/T | snv | 0.27 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98559036 | intron variant | T/C | snv | 0.40 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98560162 | intron variant | C/T | snv | 7.1E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98560374 | intron variant | C/T | snv | 0.85 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98561991 | intron variant | T/C | snv | 0.84 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98564824 | intron variant | T/C | snv | 0.84 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98565888 | intron variant | T/G | snv | 0.84 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 |